Movement Disorders (Movement Disorder)

Subscribe to Selected New Research on Movement Disorders

1454 relevant articles (89 outcomes, 143 trials/studies) found for this Disease

Description: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Also Known As:

Movement Disorder; Orofacial Dyskinesia; Movement Disorder Syndromes; Oral Dyskinesia; Dyskinesia Syndrome; Dyskinesia, Lingual-Facial-Buccal; Dyskinesia, Orofacial; Dyskinesias, Lingual-Facial-Buccal; Dyskinesias, Orofacial; Lingual Facial Buccal Dyskinesia; Lingual-Facial-Buccal Dyskinesias; Movement Disorder Syndrome; Orofacial Dyskinesias; Dyskinesia Syndromes; Etat Marbre; Lingual-Facial-Buccal Dyskinesia; Status Marmoratus

Relationship Network

Disease Context: Research Results

Nervous System Diseases: 3362

Central Nervous System Diseases: 919

Movement Disorders: 1454

Dyskinesias: 5082

Parkinsonian Disorders: 4673

Hepatolenticular Degeneration: 2036

Multiple System Atrophy: 622

Essential Tremor: 510

Progressive Supranuclear Palsy: 458

Dystonic Disorders: 340

Tic Disorders: 155

Angelman Syndrome: 144

Pantothenate Kinase-Associated Neurodegeneration: 116

Drug-Induced Akathisia: 42

Related Diseases

1.	Dystonia (Limb Dystonia)
2.	Dyskinesias (Dyskinesia)
3.	Tremor (Tremors)
4.	Parkinson Disease (Parkinson's Disease)
5.	Dystonic Disorders (Writer's Cramp)
232 Diseases and 703 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Movement Disorders:

1.	Botulinum Toxins (Botulinum Toxin)IBA 09/15/2001 - "Botulinum toxin (BTX) has been used successfully to treat various movement disorders, and is increasingly used for many other medical conditions" 02/01/2000 - "BACKGROUND: Locally administered botulinum toxin, or BTX, is an effective treatment for various movement disorders" 05/01/1997 - "Botulinum toxin is widely used for the treatment of focal movement disorders, where chemodenervation is used to decrease hyperactivity in selected muscles" 06/01/1995 - "Botulinum toxin A injection is thus a simple, safe, and effective out-patient treatment for patients with various kinds of movement disorders but it is a costly therapy." 08/01/2007 - "Following a pilot study, the 28-item Patient Knowledge Questionnaire on Botulinum Toxin Use in Movement Disorders (PKQ-BMD) was utilized to assess efficacy of current educational tools by comparing scoring of patients to that of the general population, as well as to identify information resources, target demographics for education, and key counseling topics" Get all the results and reference details, order at left...
2.	Antipsychotic Agents (Antipsychotics)IBA 01/01/2006 - "CONCLUSIONS: The use of the second-generation antipsychotics as first-line treatment of psychosis appears to have lowered the overall prevalence of acute movement disorders as well as TD, and have led them to become the standard of care in part because of their safer extrapyramidal profiles." 01/01/2006 - "One study (n=20) found no significant differences in oral dyskinesia (RR 2.45 CI 0.3 to 19.7) when neuroleptics were compared as a specific treatment for TD" 01/01/2002 - "Data from clinical trials reviewed in this article fulfill predictions based on preclinical findings that atypical antipsychotic drugs are associated with a reduced potential for inducing extrapyramidal symptoms (EPS) and other movement disorders" 01/01/1999 - "Since antipsychotic drugs are used in a variety of conditions that include psychotic features, studies have attempted to determine whether specific diagnostic subgroups may experience different degrees of vulnerability to drug-induced movement disorders" 06/01/2008 - "METHODS: The review is limited to movement disorders resulting from typical and atypical antipsychotics" Get all the results and reference details, order at left...
3.	Levodopa (L Dopa)FDA LinkGeneric 07/15/2004 - "The use of DBS of the STN and GPi is very effective for the treatment of movement disorders induced by levodopa" 05/01/1994 - "Although L-dopa decarboxylase inhibitors were markedly effective in alleviating these symptoms, an adverse reaction due to the agent was observed as the form of oral dyskinesia" 12/01/2007 - "In this article, we review recent studies in rodent models, which have uncovered two principal alterations at the basis of the movement disorder, namely, an abnormal pre-synaptic handling of exogenous L-DOPA, and a hyper-reactive post-synaptic response to DA" 08/01/2008 - "RESULTS: Both patients suffered from a progressive and complex L-dopa responsive movement disorder" 01/01/2004 - "It was found that the early stage of the disease might include isolated depression, minimal movement disorders and functional compensation, the latter being observed during L-Dopa treatment" Get all the results and reference details, order at left...
4.	Risperidone (Risperdal Consta)FDA Link 01/01/2000 - "Risperidone is less effective in achieving clinical improvement and preventing dropout but outcomes relating to movement disorders change little" 01/01/2007 - "Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD." 09/01/2005 - "Movement disorders, measured on the Extrapyramidal Symptom Rating Scale, were significantly reduced following the change to risperidone long-acting injectable" 01/01/2005 - "Risperidone is particularly associated with movement disorders and sexual dysfunction" 01/01/2005 - "The incidence of movement disorders was low, and mean Extrapyramidal Symptom Rating Scale scores decreased during risperidone treatment" Get all the results and reference details, order at left...
5.	Vitamin B 6IBA 11/01/2004 - "In earlier studies, vitamin B6 was found to be effective in the treatment of neuroleptic-induced movement disorders" 09/01/2003 - "Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders]" 07/01/2008 - "Some clinical experiments showed that vitamin B6 may ameliorate different drug-induced movement disorders, including tardive dyskinesia (TD)" 01/01/2002 - "Vitamin B6 has been reported to be effective in treatment of patients suffering from different kinds of neuroleptic-induced movement disorders including parkinsonism and tardive dyskinesia" 07/01/1999 - "Several reports have suggested that vitamin B6 (pyridoxine) can be helpful in the treatment of some neuroleptic-induced movement disorders, including parkinsonism and TD" Get all the results and reference details, order at left...
6.	Botulinum Toxin Type A (Botox)FDA Link 03/01/2005 - "OBJECTIVE: The goal of this study was to compare the safety, effectiveness, and duration of clinical effect of BOTOX and Dysport and Dysportdagger after drug switching (Dysport to BOTOX) among patients with movement disorders" 04/01/2001 - "The antinociceptive effects of botulinum toxin type A (BTX-A), based on preclinical studies and clinical experiences in treating movement disorders and other painful conditions, will also be reviewed to illustrate how this compound may act as it alleviates the discomfort associated with various conditions" 10/01/1999 - "METHODS: Patients had enrolled in a prospective study for their movement disorders, 18 cases with Botox and 22 cases with CBTX-A were studied" 09/01/1994 - "Botulinum A toxin injection is the most recent and effective treatment of various movement disorders especially focal dystonia" 04/01/2000 - "Intramuscular injection of botulinum neurotoxin A is a relatively new method for treating spastic movement disorders in children" Get all the results and reference details, order at left...
7.	olanzapine (Zyprexa)FDA Link 01/01/2008 - "Results for various movement disorders all favoured olanzapine" 06/01/2000 - "Unexpectedly low levels of striatal relative %D2/D3 receptor occupancy were seen in two patients with typical antipsychotic-drug-induced movement disorder prior to switching to olanzapine" 02/01/1997 - "Olanzapine was associated with significantly fewer adverse movement disorders (e.g" 05/01/2002 - "The authors report two cases of schizophrenia in which olanzapine proved to be an efficacious antipsychotic medication associated with the remission of movement disorder." 01/01/2003 - "Olanzapine caused greater weight gain than placebo (WMD 1.91Kg, 95% CI 1.29 to 2.53) and somnolence (RR: 2.13 95% CI 1.62 to 2.79) but not more depressive symptoms (RR: 0.95, 95% CI 0.65 to 1.40) or movement disorder (WMD: -0.33, 95% CI -0.74 to 0.09)" Get all the results and reference details, order at left...
8.	Carbamazepine (Tegretol)FDA LinkGeneric 03/01/2000 - "The movement disorder was induced by carbamazepine (CBZ) and resolved completely after discontinuation of CBZ" 08/01/1981 - "Movement disorder induced by carbamazepine." 12/01/1980 - "Carbamazepine-induced orofacial dyskinesia." 08/01/2000 - "Carbamazepine has been used successfully in the treatment of different movement disorders and was recently reported to be effective for nonhereditary chorea" 09/01/1993 - "A variety of movement disorders are known to occur in association with carbamazepine (CBZ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders" Get all the results and reference details, order at left...
9.	Trihexyphenidyl (Artane)FDA LinkGeneric 01/01/1989 - "The clinical efficacy of the trihexyphenidyl was investigated in 100 patients with movement disorders" 01/01/1989 - "Treatment of movement disorders with trihexyphenidyl." 01/01/1989 - "Three groups of movement disorders demonstrated a significant response to trihexyphenidyl: (1) dystonia 37%; tonic torticollis demonstrated a significantly better response than the clonic variant (80% vs. 22%)" 03/01/1999 - "Trihexyphenidyl has been found to be an effective treatment for dystonic movement disorders, improving gross motor function in patients with axial and torsional dystonia, tremors, and myoclonus" 12/01/1998 - "During the second-phase movement disorder, the patient had a good response to propranolol and trihexyphenidyl." Get all the results and reference details, order at left...
10.	Haloperidol (Haldol)FDA LinkGeneric 12/01/2000 - "was significantly more effective in reducing the symptoms of acute psychosis and was better tolerated than haloperidol i.m., particularly in movement disorders" 06/30/2006 - "In this study, our aim was to examine the effects of diselenide on haloperidol-induced orofacial dyskinesia in rats" 08/20/2008 - "The undesired extrapyramidal movement disorders observed with long term treatment with haloperidol have been associated with striatal neurodegeneration" 10/01/2007 - "Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats." 10/01/2007 - "Here, we examined the effects of V. officinalis, a medicinal herb widely used as calming and sleep-promoting, in an animal model of orofacial dyskinesia (OD) induced by long-term treatment with haloperidol" Get all the results and reference details, order at left...
506 Drugs and Important Bio-Agents and 1191 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Therapies and Procedures

1.	Deep Brain Stimulation 01/01/2006 - "Functional neurosurgery has benefited from these technologies, as deep brain stimulation surgery has become the standard of care for most cases of movement disorder surgery" 05/01/2004 - "Quantifying movement disorders is becoming crucially important in neurosurgery units to evaluate the efficacy of new therapeutic interventions such as deep brain stimulation" 08/27/2008 - "Because deep brain stimulation (DBS) of the posterior subthalamic nucleus (STN), which modulates the sensorimotor BG network, is beneficial in movement disorders, stimulation of the anterior, limbic STN might improve intractable behavioral disorders" 11/01/2007 - "OBJECT: Deep brain stimulation (DBS) has been shown to be an effective treatment for various types of movement disorders" 06/14/2005 - "BACKGROUND: Deep brain stimulation (DBS) is an effective treatment for several movement disorders" Get all the results and reference details, order at left...
2.	Electrodes (Electrode) 06/01/2005 - "The authors conclude that intraoperative monitoring of sEMGs of the affected muscles of patients with movement disorders during stereotactic surgery provides sensitive and quantitative information that can contribute to improved electrode or lesion placement." 01/01/1962 - "Depth electrode studies of thalamus and basal ganglia in movement disorders in man." 09/01/2008 - "Electrode stimulation of deep brain regions for movement disorders is the current practice, whereas 10 years ago the same disorders were dealt with by lesioning of the relevant regions" 06/01/2005 - "In 22 consecutive patients with various movement disorders, sEMGs were monitored in selected muscles during stereotactic surgery that involved either lesioning or electrode implantation" 06/01/2005 - "The authors present practical evidence for the usefulness of intraoperative monitoring with surface electromyograms (sEMGs) from the affected muscles to assist electrode implantation and lesioning in patients with movement disorders" Get all the results and reference details, order at left...
3.	Pallidotomy 11/01/2006 - "Surgery for movement disorders (thalamotomy, pallidotomy, and subthalamic nucleotomy or subthalamotomy) was largely ablative (lesion-based)" 06/01/2002 - "Based on the reevaluation of the results of functional neurosurgery for movement disorders from Leksell's group, pallidotomy as lesional procedure was the first functional operation that underwent a renaissance for the treatment of movement disorders" 07/01/1999 - "MATERIALS AND METHODS: Seventeen patients with medically refractory movement disorders underwent stereotactic radiosurgical pallidotomy (n = 2) or thalamotomy (n = 15)" 04/01/1998 - "The increased use of ablative movement disorder surgery, pallidotomy, and thalamotomy must be followed by our better understanding of regional neuroanatomy, use of imaging and physiologic techniques for targeting, and methods of lesion creation" 01/01/1997 - "Posteroventral pallidotomy in movement disorders." Get all the results and reference details, order at left...
4.	Anesthesia 06/01/2007 - "CONCLUSION: BIS monitoring does not improve anesthesia management for DBS electrode implantation in patients with movement disorders." 06/01/2007 - "Bispectral index monitoring does not improve anesthesia performance in patients with movement disorders undergoing deep brain stimulating electrode implantation." 01/01/2006 - "One hundred seventy-eight patients underwent an ablative procedure (n = 6) or the insertion of deep brain stimulator (n = 172) under monitored anesthesia care for movement disorders (n = 124), chronic pain (n = 20), and other procedures (n = 34)" 08/01/1998 - "Intravenous propofol anesthesia is a useful method to use with stereotactic surgery for movement disorders." 08/01/1998 - "A series of 30 patients, who underwent stereotactic surgery for movement disorder under intravenous propofol anesthesia between March, 1995 and December, 1997, was retrospectively reviewed" Get all the results and reference details, order at left...
5.	Highly Active Antiretroviral Therapy (HAART) 01/01/2002 - "Preliminary data suggest that HAART may be helpful in the symptomatic control as well as prevention of movement disorders in patients who are HIV positive." 01/01/2002 - "The management of patients who are HIV positive who present with movement disorders involves recognition and treatment of opportunistic infections, symptomatic treatment of the movement disorder and the use of highly active antiretroviral therapy (HAART)" Get all the results and reference details, order at left...
72 Therapies and Procedures and 297 more articles analyzed in the Full Patient-Physician Summary Report, order at left...

Patient-Physician Research Summary Report on Movement Disorders

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 89 Outcomes
Top 200 Key Medications
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF for "Psoriasis" >>

Price:

$24.00 & Delivery via PDF download,
updates for 1 year

Proceed to Checkout >>

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>